Coldstream-Capital-Management

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
3,538
Total Value
4381249769
Accession Number
0001082339-25-000002
Form Type
13F-HR
Manager Name
Coldstream-Capital-Management
Data Enrichment
86% identified
3,044 identified494 unidentified

Holdings

3,538 positions • $4.4B total value
Manager:
Search and click to pin securities to the top
Page 165 of 177
LendingTree, Inc.
Shares:13
Value:$654
% of Portfolio:0.0% ($654/$4.4B)
Xponential Fitness, Inc.
Shares:78
Value:$650
% of Portfolio:0.0% ($650/$4.4B)
i3 Verticals, Inc.
Shares:26
Value:$642
% of Portfolio:0.0% ($642/$4.4B)
ADC Therapeutics SA
Shares:455
Value:$642
% of Portfolio:0.0% ($642/$4.4B)
LEXICON PHARMACEUTICALS, INC.
Shares:1.4K
Value:$640
% of Portfolio:0.0% ($640/$4.4B)
MACROGENICS INC
Shares:503
Value:$639
% of Portfolio:0.0% ($639/$4.4B)
880198205
Shares:73
Value:$636
% of Portfolio:0.0% ($636/$4.4B)
PROTHENA CORP PUBLIC LTD CO
Shares:51
Value:$632
% of Portfolio:0.0% ($632/$4.4B)
California BanCorp \ CA
Shares:44
Value:$631
% of Portfolio:0.0% ($631/$4.4B)
Lyell Immunopharma, Inc.
Shares:1.2K
Value:$628
% of Portfolio:0.0% ($628/$4.4B)
ALICO, INC.
Shares:21
Value:$627
% of Portfolio:0.0% ($627/$4.4B)
Alpha Metallurgical Resources, Inc.
Shares:5
Value:$627
% of Portfolio:0.0% ($627/$4.4B)
Sight Sciences, Inc.
Shares:260
Value:$624
% of Portfolio:0.0% ($624/$4.4B)
EVgo Inc.
Shares:234
Value:$623
% of Portfolio:0.0% ($623/$4.4B)
RAPT Therapeutics, Inc.
Shares:505
Value:$617
% of Portfolio:0.0% ($617/$4.4B)
Tarsus Pharmaceuticals, Inc.
Shares:12
Value:$616
% of Portfolio:0.0% ($616/$4.4B)
Nuveen Global High Income Fund
Shares:47
Value:$615
% of Portfolio:0.0% ($615/$4.4B)
USCB FINANCIAL HOLDINGS, INC.
Shares:33
Value:$613
% of Portfolio:0.0% ($613/$4.4B)
ATN International, Inc.
Shares:30
Value:$609
% of Portfolio:0.0% ($609/$4.4B)
WESTERN ASSET HIGH INCOME FUND II INC.
Shares:145
Value:$607
% of Portfolio:0.0% ($607/$4.4B)